Skip to main content
TipRanks
Go Ultimate75% OFF

NeuroPace (NPCE) Stock Statistics & Valuation Metrics

144 Followers

Total Valuation

NeuroPace has a market cap or net worth of $282.50M. The enterprise value is $492.92M.

Market Cap
$282.50M
Enterprise Value
$492.92M

Share Statistics

NeuroPace has 34,451,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
34,451,570
Owned by Insiders
16.63%
Owned by Institutions
75.05%

Financial Efficiency

NeuroPace’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -18.18%.

Return on Equity (ROE)
-1.13
Return on Assets (ROA)
-0.20
Return on Invested Capital (ROIC)
-18.18%
Return on Capital Employed (ROCE)
-0.19
Revenue Per Employee
462.90K
Profits Per Employee
-99.38K
Employee Count
216
Asset Turnover
0.95
Inventory Turnover
1.35

Valuation Ratios

The current PE Ratio of NeuroPace is -14.63. NeuroPace’s PEG ratio is -0.47.

PE Ratio
-14.63
PS Ratio
2.99
PB Ratio
24.57
Price to FCF
-22.81
Price to Operating Cash Flow
-23.41
PEG Ratio
-0.47

Income Statement

In the last 12 months, NeuroPace had revenue of 99.99M and earned -21.46M in profits. Earnings per share was -0.66.

Revenue
99.99M
Gross Profit
77.22M
Operating Income
-16.34M
Pretax Income
-21.46M
Net Income
-21.46M
EBITDA
-12.06M
Earnings Per Share (EPS)
-0.66

Cash Flow

In the last 12 months, operating cash flow was -12.06M and capital expenditures -355,000, giving a free cash flow of -12.41M billion.

Operating Cash Flow
-12.06M
Free Cash Flow
-12.41M
Free Cash Flow per Share
-0.36

Dividends & Yields

NeuroPace pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-4.38%
Earnings Yield
-6.70%

Stock Price Statistics

Beta
0.50
52-Week Price Change
-36.87%
50-Day Moving Average
13.07
200-Day Moving Average
14.71
Relative Strength Index (RSI)
26.46
Average Volume (3m)
254.94K

Important Dates

NeuroPace upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 09, 2027
Ex-Dividend Date
―

Financial Position

NeuroPace as a current ratio of 5.28, with Debt / Equity ratio of 372.22%

Current Ratio
5.28
Quick Ratio
4.33
Debt to Market Cap
0.12
Net Debt to EBITDA
-4.08
Interest Coverage Ratio
-2.19

Taxes

In the past 12 months, NeuroPace has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

NeuroPace EV to EBITDA ratio is -31.01, with an EV/FCF ratio of -27.59.

EV to Sales
3.62
EV to EBITDA
-31.01
EV to Free Cash Flow
-27.59
EV to Operating Cash Flow
-28.40

Balance Sheet

NeuroPace has $49.23M in cash and marketable securities with $69.54M in debt, giving a net cash position of -$20.31M billion.

Cash & Marketable Securities
$49.23M
Total Debt
$69.54M
Net Cash
-$20.31M
Net Cash Per Share
-$0.59
Tangible Book Value Per Share
$0.33

Margins

Gross margin is 81.41%, with operating margin of -15.39%, and net profit margin of -20.00%.

Gross Margin
81.41%
Operating Margin
-15.39%
Pretax Margin
-20.00%
Net Profit Margin
-20.00%
EBITDA Margin
-11.68%
EBIT Margin
-13.42%

Analyst Forecast

The average price target for NeuroPace is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$11.00
Price Target Upside
33.82% Upside
Analyst Consensus
Moderate Buy
Analyst Count
8
Revenue Growth Forecast
-0.29%
EPS Growth Forecast
25.96%

Scores

Smart Score
4
AI Score
40